Fitness Trends Enteral Nutrition Market

Enteral Nutrition Market - Size, Share, Trends, and Forecast to 2025 Enteral nutrition, also known as tube feeding refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver caloric requirements, including normal oral diet or liquid supplements. Nasoenteral, also known as nasogastric feeding tube is placed in the stomach through the nose, whereas a jejunostomy tube is placed directly through the skin. The tube feeding formula is used in patients suffering from chronic conditions including head trauma, cancer, and strokes. Moreover, the formula helps premature infants to gain required nutrition and medications. According to the National Center for Biotechnology Information (NCBI), nasogastric tube is most preferred method for short term feeding in the acute phase of stroke and is commonly used for providing nutrition, hydration, and essential medications. Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1115 Market Dynamics Rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and neurological diseases are some of the major factors complementing growth of this market. According to the National Center for Biotechnology Information (NCBI), the prevalence of chronic disease has increased from 34.9% to 41.8% during 2004-2011. Rising number of preterm births and increasing geriatric population across the global are some of the key factors supporting growth of this market. According to the National Institutes of Health (NIH), the world’s older population is steadily growing and 8.5% of people worldwide (approximately 617 million) were recorded aging 65 and older in 2016. Major factors propelling growth of the global enteral nutrition market are rising prevalence of chronic diseases such as diabetes, heart disease, and cancer coupled with increasing health care expenditure, worldwide. According to the American Diabetes Association (ADA), long term use of nutritional support with diabetes specific formula helps reducing chronic complications of